DrugDashboards

Market view

lefamulin acetate

3 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for lefamulin acetate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • XenletaJul 24, 2026
    Mfr entered
    Meitheal Pharmaceuticals Inc. · lefamulin acetate
  • XenletaJul 24, 2026
    Mfr entered
    Meitheal Pharmaceuticals Inc. · lefamulin acetate
  • XenletaJul 24, 2026
    New product
    Meitheal Pharmaceuticals Inc.
  • XenletaJul 24, 2026
    New product
    Meitheal Pharmaceuticals Inc.

Common questions

Is Lefamulin acetate in shortage right now?
No. FDA does not currently list Lefamulin acetate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Lefamulin acetate?
2 companies have marketed Lefamulin acetate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.